TLDR: LEON (LLM-based Entropy-guided Optimization with kNowledgeable priors) is a new method that uses large language models (LLMs) as black-box optimizers for personalized medicine. It addresses challenges like surrogate model limitations and distribution shifts by incorporating domain-specific prior knowledge and two key constraints: one ensuring proposed treatments are similar to historical data (source critic) and another guiding the LLM towards confident proposals (entropy-guided). LEON leverages LLMs to query external knowledge bases and reflect on optimization progress. Experiments on five real-world tasks show LEON consistently outperforms traditional and other LLM-based methods in proposing individualized treatments, achieving an average rank of 1.2.
Personalized medicine aims to tailor treatment plans to each patient’s unique genetic and environmental makeup. This approach promises to optimize clinical outcomes by moving beyond one-size-fits-all therapies. However, achieving true personalization presents significant hurdles. One major challenge is the difficulty of evaluating new treatments directly on patients due to cost and ethical concerns. Instead, researchers often rely on ‘in silico’ surrogate models that approximate a treatment’s effectiveness. Unfortunately, these surrogate models frequently struggle to generalize to new patient-treatment combinations, especially when dealing with diverse patient populations not well-represented in initial studies.
A new research paper introduces an innovative solution called LEON (LLM-based Entropy-guided Optimization with kNowledgeable priors). This approach leverages the power of large language models (LLMs) as ‘black-box optimizers’ to propose personalized treatment plans. What makes LEON stand out is its ability to integrate domain-specific prior knowledge—like medical textbooks and biomedical knowledge graphs—to guide the optimization process without requiring any task-specific fine-tuning of the LLM itself. The paper, titled “KNOWLEDGEABLE LANGUAGE MODELS AS BLACK-BOX OPTIMIZERS FOR PERSONALIZED MEDICINE,” explores how LLMs can contextualize unstructured medical knowledge to make informed treatment recommendations.
How LEON Works: Optimization by Prompting
LEON operates through a method called ‘optimization by prompting.’ In essence, the LLM acts as a stochastic engine that iteratively proposes treatment designs. The process involves several key steps:
First, the problem of personalized medicine is framed as a conditional black-box optimization task. This means the goal is to find the best treatment regimen for a specific patient, given their unique characteristics, to optimize a target clinical outcome. Since direct evaluation of treatments on humans is impractical, LEON works with a surrogate model that estimates treatment quality.
To overcome the limitations of imperfect surrogate models, LEON introduces two crucial constraints:
- Source Critic Constraint: This constraint ensures that the proposed treatment designs are not too dissimilar from historically reported treatments. It uses an ‘adversarial source critic’ model to measure the difference between the distribution of proposed designs and a dataset of previous real-world treatments. By limiting this difference, LEON reduces the risk of proposing treatments that look good to the surrogate model but would perform poorly in reality due to being ‘out-of-distribution.’ Importantly, this constraint respects patient privacy by only using information about past treatments, not individual patient data from the source dataset.
- Entropy-Guided Constraint: This constraint encourages the LLM to propose designs with high certainty. It places an upper bound on the ‘coarse-grained entropy’ of the distribution of proposed designs. In simpler terms, if the LLM consistently suggests similar high-quality treatments when prompted, it indicates higher confidence in its proposals. This certainty is boosted by leveraging domain-specific prior knowledge.
LEON dynamically calculates ‘certainty parameters’ (lambda and mu) that balance the importance of these two constraints. Lambda upweights designs that are ‘in-distribution’ according to the source critic, while mu upweights designs where the LLM shows high confidence.
Leveraging Prior Knowledge and Reflection
A cornerstone of LEON is its ability to integrate external domain knowledge. The LLM is given access to various knowledge repositories, such as medical textbooks, specialized medical LLMs (like MedGemma), and biomedical knowledge graphs (like HetioNet and PrimeKG). Given a patient’s features and the optimization task, the LLM acts as a ‘tool-calling’ agent, querying these sources to synthesize a relevant prior knowledge statement in natural language. This statement is then included in the LLM’s prompt during optimization, helping it propose higher-quality designs and increase its certainty.
Furthermore, after each batch of designs is scored, the LLM is prompted to ‘reflect’ on the data and its sampling strategy. This reflection, also in natural language, helps the LLM analyze what worked and what didn’t, from both an optimization and a biomedical perspective, further refining its approach in subsequent iterations.
Empirical Success in Real-World Tasks
The researchers evaluated LEON on five real-world personalized medicine optimization tasks, all designed to simulate distribution shifts where the surrogate model might struggle. These tasks included:
- Warfarin dose prediction (a blood thinner)
- HIV antiretroviral medication regimen design
- Breast cancer treatment strategy
- Non-small cell lung cancer (NSCLC) treatment strategy
- Adverse Drug Reaction (ADR) risk prediction
LEON was compared against ten other baseline methods, including traditional optimizers (like Gradient Ascent and Bayesian Optimization) and other LLM-based optimization techniques (like OPRO and Eureka). The results were striking: LEON consistently outperformed all baselines, achieving an average rank of 1.2 across the tasks. Notably, LEON proposed personalized treatment designs that were often superior to the treatments retrospectively received by patients in the target dataset, even outperforming a ‘Human’ baseline in several cases.
Ablation studies confirmed the importance of LEON’s components, showing that the quality of the backbone LLM, the availability of high-quality prior knowledge, and the reflection mechanism all significantly impact performance. For instance, providing irrelevant or factually incorrect knowledge severely degraded results, highlighting the need for careful knowledge vetting.
Also Read:
- A New Approach to Quantifying Uncertainty in Large Language Models for Medical Diagnosis
- A Reflective AI Architecture for Clearer and More Accurate Medical Predictions
Conclusion and Future Directions
LEON offers a mathematically principled and computationally tractable approach to using LLMs as black-box optimizers for personalized medicine. By combining domain knowledge with LLM-based optimization, it addresses critical challenges like distribution shifts and the limitations of surrogate models, all without requiring extensive fine-tuning of the LLM itself. This work represents a significant step towards leveraging advanced AI for individualized healthcare.
While promising, the authors acknowledge limitations, including the sensitivity of LLM optimizers to the quality of prior knowledge and the inherent complexities of real-world patient responses that simulations cannot fully capture. Future work aims to extend LEON to active learning settings and integrate physician oversight to ensure safety and efficacy in clinical deployment. For more details, you can refer to the full research paper.
